Portugal – Immune sera and immunoglobulins – 2024/0963 - NIRSEVIMAB [50 MG/0.5 ML SOL INJ SERINGA]
Tender Description
NIRSEVIMAB [50 MG/0.5 ML SOL INJ SERINGA]
Unlock Full Tender Insight
Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.
It's free to get started. No credit card required.
